Digital Diagnostics is paving the way for automated diagnosis to become the new standard of care. Founded in 2010 by Dr. Michael Abramoff, a physician/scientist and computer engineer, Digital Diagnostics has created a unique, patented biomarker-based approach to build algorithms to “think” like a physician. These algorithms are integrated into easy-to-use systems that can make clinical decisions without human intervention, removing the diagnostic burden of common diseases from specialists. The FDA cleared Digital Diagnostics’ first diagnostic system for diabetic retinopathy (including diabetic macular edema) in 2018, which is rapidly gaining adoption among the largest and most prestigious health systems in the U.S and around the world.